Timothy Pickett - 22 Sep 2025 Form 4 Insider Report for Kindly MD, Inc. (NAKA)

Role
Chief Medical Officer, Director
Signature
/s/ Kyle Simon, as attorney-in-fact
Issuer symbol
NAKA
Transactions as of
22 Sep 2025
Net transactions value
$0
Form type
4
Filing time
24 Sep 2025, 21:46:40 UTC
Previous filing
14 May 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Pickett Timothy Chief Medical Officer, Director 5097 SOUTH 900 EAST, SUITE 100, SALT LAKE CITY /s/ Kyle Simon, as attorney-in-fact 24 Sep 2025 0002002575

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NAKA Common Stock Award $0 +37,593 +38% $0.000000 136,618 22 Sep 2025 Direct F1
transaction NAKA Common Stock Award $0 +26,129 +19% $0.000000 162,747 22 Sep 2025 Direct F2
transaction NAKA Common Stock Award $0 +10,146 +6.2% $0.000000 172,893 22 Sep 2025 Direct F3
transaction NAKA Common Stock Award $0 +18,378 +11% $0.000000 191,271 22 Sep 2025 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This reflects restricted stock units ("RSUs") that shall time-vest over a four (4) year period, with no vesting during the first twelve (12) months following August 15, 2025 (the "Cliff Period"), and thereafter twenty-five percent (25%) of the RSUs shall vest upon completion of the Cliff Period, with the remaining seventy-five percent (75%) of the RSUs vesting in equal quarterly installments over the subsequent thirty six (36) months, subject to the reporting person's continued service to the issuer through each applicable vesting date.
F2 This reflects a restricted stock award that was fully vested as of September 22, 2025.
F3 This reflects a restricted stock award that was fully vested as of September 22, 2025.
F4 This reflects a restricted stock award that was fully vested as of September 22, 2025.

Remarks:

Exhibit 24 - Power of Attorney